Literature DB >> 23019223

Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.

Anne F Rositch1, Anne E Burke, Raphael P Viscidi, Michelle I Silver, Kathryn Chang, Patti E Gravitt.   

Abstract

Understanding the fraction of newly detected human papillomavirus (HPV) infections due to acquisition and reactivation has important implications on screening strategies and prevention of HPV-associated neoplasia. Information on sexual activity and cervical samples for HPV DNA detection using Roche Linear Array were collected semiannually for two years from 700 women ages 35 to 60 years. Incidence and potential fraction of HPV associated with new and lifetime sexual partnerships were estimated using Poisson regression. Cox frailty models were used to estimate hazard ratios (HR) for potential risk factors of incident HPV detection. Recent and lifetime numbers of sexual partners were both strongly associated with incident HPV detection. However, only 13% of incident detections were attributed to new sexual partners, whereas 72% were attributed to 5 or more lifetime sexual partners. Furthermore, 155 of 183 (85%) incident HPV detections occurred during periods of sexual abstinence or monogamy, and were strongly associated with cumulative lifetime sexual exposure [HR: 4.1, 95% confidence interval (CI): 2.0-8.4). This association increased with increasing age. These data challenge the paradigm that incident HPV detection is driven by current sexual behavior and new viral acquisition in older women. Our observation that most incident HPV infection was attributable to past, not current, sexual behavior at older ages supports a natural history model of viral latency and reactivation. As the more highly exposed baby-boomer generation of women with sexual debut after the sexual revolution transition to menopause, the implications of HPV reactivation at older ages on cervical cancer risk and screening recommendations should be carefully evaluated.

Entities:  

Mesh:

Year:  2012        PMID: 23019223      PMCID: PMC3513486          DOI: 10.1158/0008-5472.CAN-12-2635

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Proportional hazards model with random effects.

Authors:  F Vaida; R Xu
Journal:  Stat Med       Date:  2000-12-30       Impact factor: 2.373

2.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  A heuristic approach to the formulas for population attributable fraction.

Authors:  J A Hanley
Journal:  J Epidemiol Community Health       Date:  2001-07       Impact factor: 3.710

4.  The estimation and interpretation of attributable risk in health research.

Authors:  S D Walter
Journal:  Biometrics       Date:  1976-12       Impact factor: 2.571

5.  Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

Authors:  François Coutlée; Patti Gravitt; Janet Kornegay; Catherine Hankins; Harriet Richardson; Normand Lapointe; Hélène Voyer; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

7.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.

Authors:  Rachel L Winer; Shu-Kuang Lee; James P Hughes; Diane E Adam; Nancy B Kiviat; Laura A Koutsky
Journal:  Am J Epidemiol       Date:  2003-02-01       Impact factor: 4.897

8.  Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

Authors:  Philip E Castle; Andrew G Glass; Brenda B Rush; David R Scott; Nicolas Wentzensen; Julia C Gage; Julie Buckland; Greg Rydzak; Attila T Lorincz; Sholom Wacholder
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

10.  Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.

Authors:  Anna R Giuliano; Robin Harris; Rebecca L Sedjo; Susie Baldwin; Denise Roe; Mary R Papenfuss; Martha Abrahamsen; Paula Inserra; Sandra Olvera; Kenneth Hatch
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

View more
  49 in total

1.  Importance of Lifetime Sexual History on the Prevalence of Genital Human Papillomavirus (HPV) Among Unvaccinated Adults in the National Health and Nutrition Examination Surveys: Implications for Adult HPV Vaccination.

Authors:  Anne F Rositch; Eshan U Patel; Molly R Petersen; Thomas C Quinn; Patti E Gravitt; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

2.  Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection.

Authors:  Lauren Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  J Infect Dis       Date:  2014-02-25       Impact factor: 5.226

3.  Sinecatechins Ointment, 15% for the Treatment of External Genital and Perianal Warts: Proceedings of an Expert Panel Roundtable Meeting.

Authors:  Gary Goldenberg; Maida Taylor; Brian Berman; Mark Kaufmann; William Abramovits; Joshua Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

4.  The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.

Authors:  Nadja Vielot; Michael G Hudgens; Nelly Mugo; Michael Chitwa; Joshua Kimani; Jennifer Smith
Journal:  Sex Transm Dis       Date:  2015-06       Impact factor: 2.830

5.  Human Papillomavirus DNA Detection in Older Women-Implications for Cancer Screening and Prevention.

Authors:  Aaron C Ermel; Kenneth H Fife
Journal:  J Infect Dis       Date:  2016-03-23       Impact factor: 5.226

6.  Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study.

Authors:  Shitaldas J Pamnani; Alan G Nyitray; Martha Abrahamsen; Dana E Rollison; Luisa L Villa; Eduardo Lazcano-Ponce; Yangxin Huang; Amy Borenstein; Anna R Giuliano
Journal:  J Infect Dis       Date:  2016-08-03       Impact factor: 5.226

Review 7.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

8.  Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study.

Authors:  Shitaldas J Pamnani; Staci L Sudenga; Dana E Rollison; Donna J Ingles; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Yangxin Huang; Amy Borenstein; Anna R Giuliano
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

9.  Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Authors:  Tsung-Chieh Jane Fu; Joseph J Carter; James P Hughes; Qinghua Feng; Stephen E Hawes; Stephen M Schwartz; Long Fu Xi; Taylor Lasof; Joshua E Stern; Denise A Galloway; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2016-08-04       Impact factor: 7.396

10.  Natural history of anal vs oral HPV infection in HIV-infected men and women.

Authors:  Daniel C Beachler; Gypsyamber D'Souza; Elizabeth A Sugar; Wiehong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2013-04-17       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.